<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药魔方Pro | wechat-feeds</title><link>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</link><description>聚焦生物医药前沿，洞察研发投资风向</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 02 Feb 2021 21:03:14 +0800</pubDate><image><url>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</url><title>医药魔方Pro | wechat-feeds</title><link>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>陈枢青点评 | 新抗原疫苗：开启癌症免疫治疗2.0时代</title><link>https://mp.weixin.qq.com/s/dvrF6zgj_4U4tIxIrmhmaw</link><description></description><content:encoded><![CDATA[陈枢青点评 | 新抗原疫苗：开启癌症免疫治疗2.0时代]]></content:encoded><pubDate>Tue, 02 Feb 2021 20:58:32 +0800</pubDate></item><item><title>小分子偶联药物：传奇佳话，能否续写？</title><link>https://mp.weixin.qq.com/s/cW81Kz4x0miLNuPGGUfbug</link><description></description><content:encoded><![CDATA[小分子偶联药物：传奇佳话，能否续写？]]></content:encoded><pubDate>Mon, 01 Feb 2021 20:58:34 +0800</pubDate></item><item><title>GSK押注痤疮CRISPR疗法，2.24亿美元的大交易揭示了什么……</title><link>https://mp.weixin.qq.com/s/gekab2aNMjJgbaMA3GDKFw</link><description></description><content:encoded><![CDATA[GSK押注痤疮CRISPR疗法，2.24亿美元的大交易揭示了什么……]]></content:encoded><pubDate>Sun, 31 Jan 2021 20:58:52 +0800</pubDate></item><item><title>Nature最新报告：乳腺癌药物市场2029年预计达477亿美元，CDK4/6抑制剂或成最大赢家！</title><link>https://mp.weixin.qq.com/s/bUb6OXqae55kFPhYSwvDpA</link><description></description><content:encoded><![CDATA[Nature最新报告：乳腺癌药物市场2029年预计达477亿美元，CDK4/6抑制剂或成最大赢家！]]></content:encoded><pubDate>Sat, 30 Jan 2021 20:58:44 +0800</pubDate></item><item><title>Nature里程碑：糖尿病治疗新靶点——胰岛素抑制受体</title><link>https://mp.weixin.qq.com/s/xlbPcACeAF9lka0SVSyQFw</link><description></description><content:encoded><![CDATA[Nature里程碑：糖尿病治疗新靶点——胰岛素抑制受体]]></content:encoded><pubDate>Fri, 29 Jan 2021 21:00:37 +0800</pubDate></item><item><title>AAV基因疗法火热！Nature最新报告揭示：4大热门靶器官、TOP10适应证</title><link>https://mp.weixin.qq.com/s/aAvRCl7jHRSPt-0vpNouvg</link><description></description><content:encoded><![CDATA[AAV基因疗法火热！Nature最新报告揭示：4大热门靶器官、TOP10适应证]]></content:encoded><pubDate>Thu, 28 Jan 2021 21:00:10 +0800</pubDate></item><item><title>大大提高安全性！胰腺癌CAR-T疗法新靶点——CEACAM7</title><link>https://mp.weixin.qq.com/s/nwpWZ4Z60GW46AFnOaR07w</link><description></description><content:encoded><![CDATA[大大提高安全性！胰腺癌CAR-T疗法新靶点——CEACAM7]]></content:encoded><pubDate>Wed, 27 Jan 2021 20:58:20 +0800</pubDate></item><item><title>全球首个申报临床的BTK-PROTAC，来了！</title><link>https://mp.weixin.qq.com/s/SvkYQwo_TeqjVw5NNTnb8g</link><description></description><content:encoded><![CDATA[全球首个申报临床的BTK-PROTAC，来了！]]></content:encoded><pubDate>Tue, 26 Jan 2021 13:20:45 +0800</pubDate></item><item><title>开发神经退行性疾病远程检测方法！Innodem Neurosciences获晨兴创投600万美元A轮投资</title><link>https://mp.weixin.qq.com/s/wkydmkTyqcx9v4_ywIPjUQ</link><description></description><content:encoded><![CDATA[开发神经退行性疾病远程检测方法！Innodem Neurosciences获晨兴创投600万美元A轮投资]]></content:encoded><pubDate>Tue, 26 Jan 2021 13:20:45 +0800</pubDate></item><item><title>癌症免疫治疗新靶点——NIK</title><link>https://mp.weixin.qq.com/s/7SVTIdydygRc8bb0O8QaIw</link><description></description><content:encoded><![CDATA[癌症免疫治疗新靶点——NIK]]></content:encoded><pubDate>Mon, 25 Jan 2021 21:00:20 +0800</pubDate></item><item><title>【最新报告】实体瘤细胞和基因治疗全球研发格局</title><link>https://mp.weixin.qq.com/s/a_CgAHgOSkLPN79UM3BzRw</link><description></description><content:encoded><![CDATA[【最新报告】实体瘤细胞和基因治疗全球研发格局]]></content:encoded><pubDate>Sun, 24 Jan 2021 20:59:11 +0800</pubDate></item></channel></rss>